產品詳情
簡單介紹：
Anti-C6orf145抗體產品質量穩定，實驗效果明顯，貨期快，價格優惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-C6orf145抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-C6orf145
Cat. Number:
Anti-C6orf145抗體KL-15222R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Making up nearly 6% of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tardaAnti-C6orf145抗體 is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf145 gene product has been provisionally designated C6orf145 pending further characterization.
Also known as:
C6orf145; PXDC1_HUMAN; Anti-C6orf145抗體Chromosome 6 open reading frame 145; PX domain containing 1; PX domain-containing protein C6orf145.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C6orf145.
●
Predicted Molecular Weight: 27kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-C6orf145抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutionsAnti-C6orf145抗體 must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutionsAnti-C6orf145抗體 must be determined by the end user.
kl084Mu02 瘦素(LEP)多克隆抗體 Polyclonal Antibody to Leptin (LEP)
kl086Mu02 L選擇素(SELL)多克隆抗體 Polyclonal Antibody to Selectin, Leukocyte (SELL)
kl087Mi02 單核細胞趨化蛋白1(MCP1)多克隆抗體 Polyclonal Antibody to Monocyte Chemotactic Protein 1 (MCP1)
kl089Mu02 單核細胞趨化蛋白3(MCP3)多克隆抗體 Polyclonal Antibody to Monocyte Chemotactic Protein 3 (MCP3)
kl090Mu02 巨噬細胞集落刺激因子(MCSF)多克隆抗體 Polyclonal Antibody to Colony Stimulating Factor 1, Macrophage (MCSF)
kl091Mu02 巨噬細胞來源趨化因子(MDC)多克隆抗體 Polyclonal Antibody to Macrophage Derived Chemokine (MDC)
kl092Mu02 巨噬細胞炎性蛋白1α(MIP1α)多克隆抗體 Polyclonal Antibody to Macrophage Inflammatory Protein 1 Alpha (MIP1a)
kl093Mu02 巨噬細胞炎性蛋白1β(MIP1β)多克隆抗體 Polyclonal Antibody to Macrophage Inflammatory Protein 1 Beta (MIP1b)
kl095Mu02 巨噬細胞炎性蛋白3α(MIP3α)多克隆抗體 Polyclonal Antibody to Macrophage Inflammatory Protein 3 Alpha (MIP3a)
kl096Mu02 巨噬細胞炎性蛋白3β(MIP3β)多克隆抗體 Polyclonal Antibody to Macrophage Inflammatory Protein 3 Beta (MIP3b)
kl097Mu02 基質金屬蛋白酶1(MMP1)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 1 (MMP1)
kl098Mu02 基質金屬蛋白酶10(MMP10)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 10 (MMP10)
kl100Eq01 基質金屬蛋白酶2(MMP2)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 2 (MMP2)
kl100Mu02 基質金屬蛋白酶2(MMP2)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 2 (MMP2)
kl100Po01 基質金屬蛋白酶2(MMP2)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 2 (MMP2)
kl101Mu02 基質金屬蛋白酶3(MMP3)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 3 (MMP3)
kl102Mu02 基質金屬蛋白酶7(MMP7)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 7 (MMP7)
kl103Mu02 基質金屬蛋白酶8(MMP8)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 8 (MMP8)
